Chimerix, the manufacturer of the herpesvirus drug, brincidofovir (formerly known as CMX001), recently went public and the guess is that they're very confident about getting FDA approval. On your alternative treatments page you note brincidofovir appears to be 100x's more powerful that Read more [...]
It could explain the disappointing Lipkin Chronic Fatigue Initiative pathogen study results. It shows how an infection could trigger ME/CFS and then - poof - seemingly disappear. It includes two hot research topics in ME/CFS; the autonomic nervous and immune systems. It explains how sickness Read more [...]
Fibromyalgia, not chronic fatigue syndrome, is going be the recipient of the first large, multi-center antiviral treatment trial. In an entirely new approach to FM, Dr. Skip Pridgen is using a novel two-drug approach, to smother the herpesviruses he believes are causing the disorder (and ME/CFS Read more [...]
Dr. Ian Lipkin surprised everyone on the CDC's Conference call yesterday when he presented many of the results from the two major pathogen studies involving the Chronic Fatigue Syndrome Initiative and Dr. Montoya at Stanford.
These studies, easily the most rigorous of their type ever attempted Read more [...]